Matthew Winton - Oct 6, 2025 Form 4 Insider Report for CervoMed Inc. (CRVO)

Role
Chief Commercial and Business
Signature
/s/ Matthew Winton
Stock symbol
CRVO
Transactions as of
Oct 6, 2025
Transactions value $
$0
Form type
4
Date filed
10/8/2025, 04:07 PM
Previous filing
Jul 3, 2025
Next filing
Nov 17, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Winton Matthew Chief Commercial and Business C/O CERVOMED INC., 20 PARK PLAZA, SUITE 424, BOSTON /s/ Matthew Winton 2025-10-07 0001971400

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRVO Stock Option (Right to Buy) Award $0 +75K $0.00 75K Oct 6, 2025 Common Stock 75K $8.62 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares granted as an inducement award material to Dr. Winton's entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). Award vests in equal monthly installments over thirty-six (36) months on the last day of each month commencing October 31, 2025.